nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—Distention—Octreotide—thymus cancer	0.128	0.205	CcSEcCtD
Loperamide—Abdominal bloating—Octreotide—thymus cancer	0.0633	0.101	CcSEcCtD
Loperamide—Epigastric pain—Octreotide—thymus cancer	0.0624	0.1	CcSEcCtD
Loperamide—Abdominal cramps—Octreotide—thymus cancer	0.0446	0.0716	CcSEcCtD
Loperamide—POMC—neck—thymus cancer	0.0393	0.106	CbGeAlD
Loperamide—POMC—hematopoietic system—thymus cancer	0.0292	0.0789	CbGeAlD
Loperamide—Anaphylactoid reaction—Octreotide—thymus cancer	0.0226	0.0362	CcSEcCtD
Loperamide—POMC—pituitary gland—thymus cancer	0.0217	0.0585	CbGeAlD
Loperamide—POMC—lymphoid tissue—thymus cancer	0.0206	0.0555	CbGeAlD
Loperamide—Abdominal pain upper—Octreotide—thymus cancer	0.02	0.032	CcSEcCtD
Loperamide—Abdominal distension—Octreotide—thymus cancer	0.019	0.0305	CcSEcCtD
Loperamide—POMC—thyroid gland—thymus cancer	0.0187	0.0505	CbGeAlD
Loperamide—POMC—lung—thymus cancer	0.017	0.0458	CbGeAlD
Loperamide—Drowsiness—Octreotide—thymus cancer	0.0169	0.027	CcSEcCtD
Loperamide—Immune system disorder—Octreotide—thymus cancer	0.0137	0.0219	CcSEcCtD
Loperamide—Flatulence—Octreotide—thymus cancer	0.013	0.0208	CcSEcCtD
Loperamide—Loss of consciousness—Octreotide—thymus cancer	0.0116	0.0186	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.0111	0.0179	CcSEcCtD
Loperamide—Discomfort—Octreotide—thymus cancer	0.0111	0.0178	CcSEcCtD
Loperamide—OPRM1—hematopoietic system—thymus cancer	0.011	0.0297	CbGeAlD
Loperamide—Dry mouth—Octreotide—thymus cancer	0.011	0.0176	CcSEcCtD
Loperamide—Anaphylactic shock—Octreotide—thymus cancer	0.0108	0.0172	CcSEcCtD
Loperamide—CALM2—neck—thymus cancer	0.0107	0.029	CbGeAlD
Loperamide—CALM1—neck—thymus cancer	0.0107	0.0288	CbGeAlD
Loperamide—Nervous system disorder—Octreotide—thymus cancer	0.0105	0.0169	CcSEcCtD
Loperamide—Skin disorder—Octreotide—thymus cancer	0.0104	0.0167	CcSEcCtD
Loperamide—Somnolence—Octreotide—thymus cancer	0.00956	0.0153	CcSEcCtD
Loperamide—Dyspepsia—Octreotide—thymus cancer	0.00946	0.0152	CcSEcCtD
Loperamide—Gastrointestinal disorder—Octreotide—thymus cancer	0.00928	0.0149	CcSEcCtD
Loperamide—Fatigue—Octreotide—thymus cancer	0.00927	0.0149	CcSEcCtD
Loperamide—Constipation—Octreotide—thymus cancer	0.00919	0.0147	CcSEcCtD
Loperamide—Gastrointestinal pain—Octreotide—thymus cancer	0.00879	0.0141	CcSEcCtD
Loperamide—Urticaria—Octreotide—thymus cancer	0.00854	0.0137	CcSEcCtD
Loperamide—Abdominal pain—Octreotide—thymus cancer	0.0085	0.0136	CcSEcCtD
Loperamide—CALM2—hematopoietic system—thymus cancer	0.00799	0.0215	CbGeAlD
Loperamide—CALM1—hematopoietic system—thymus cancer	0.00795	0.0215	CbGeAlD
Loperamide—Hypersensitivity—Octreotide—thymus cancer	0.00792	0.0127	CcSEcCtD
Loperamide—CALM3—cardiac atrium—thymus cancer	0.00772	0.0208	CbGeAlD
Loperamide—Asthenia—Octreotide—thymus cancer	0.00771	0.0124	CcSEcCtD
Loperamide—Pruritus—Octreotide—thymus cancer	0.00761	0.0122	CcSEcCtD
Loperamide—CALM3—pituitary gland—thymus cancer	0.00754	0.0204	CbGeAlD
Loperamide—Diarrhoea—Octreotide—thymus cancer	0.00736	0.0118	CcSEcCtD
Loperamide—CALM2—epithelium—thymus cancer	0.0073	0.0197	CbGeAlD
Loperamide—CALM1—epithelium—thymus cancer	0.00727	0.0196	CbGeAlD
Loperamide—Dizziness—Octreotide—thymus cancer	0.00711	0.0114	CcSEcCtD
Loperamide—Vomiting—Octreotide—thymus cancer	0.00684	0.011	CcSEcCtD
Loperamide—Rash—Octreotide—thymus cancer	0.00678	0.0109	CcSEcCtD
Loperamide—Dermatitis—Octreotide—thymus cancer	0.00677	0.0109	CcSEcCtD
Loperamide—Headache—Octreotide—thymus cancer	0.00674	0.0108	CcSEcCtD
Loperamide—CYP2C8—hematopoietic system—thymus cancer	0.00662	0.0179	CbGeAlD
Loperamide—CALM3—bone marrow—thymus cancer	0.00652	0.0176	CbGeAlD
Loperamide—CALM3—thyroid gland—thymus cancer	0.0065	0.0175	CbGeAlD
Loperamide—Nausea—Octreotide—thymus cancer	0.00639	0.0102	CcSEcCtD
Loperamide—CALM2—cardiac atrium—thymus cancer	0.00606	0.0164	CbGeAlD
Loperamide—CALM1—cardiac atrium—thymus cancer	0.00604	0.0163	CbGeAlD
Loperamide—CYP2B6—hematopoietic system—thymus cancer	0.00594	0.016	CbGeAlD
Loperamide—CALM2—pituitary gland—thymus cancer	0.00592	0.016	CbGeAlD
Loperamide—CALM3—lung—thymus cancer	0.00591	0.0159	CbGeAlD
Loperamide—CALM1—pituitary gland—thymus cancer	0.0059	0.0159	CbGeAlD
Loperamide—CALM2—lymphoid tissue—thymus cancer	0.00562	0.0152	CbGeAlD
Loperamide—CALM1—lymphoid tissue—thymus cancer	0.0056	0.0151	CbGeAlD
Loperamide—CALM2—bone marrow—thymus cancer	0.00512	0.0138	CbGeAlD
Loperamide—CALM2—thyroid gland—thymus cancer	0.00511	0.0138	CbGeAlD
Loperamide—CALM1—bone marrow—thymus cancer	0.0051	0.0138	CbGeAlD
Loperamide—CALM1—thyroid gland—thymus cancer	0.00508	0.0137	CbGeAlD
Loperamide—CYP2C8—pituitary gland—thymus cancer	0.00491	0.0132	CbGeAlD
Loperamide—CALM2—lung—thymus cancer	0.00464	0.0125	CbGeAlD
Loperamide—CALM1—lung—thymus cancer	0.00462	0.0125	CbGeAlD
Loperamide—CYP3A4—hematopoietic system—thymus cancer	0.00448	0.0121	CbGeAlD
Loperamide—CYP2D6—hematopoietic system—thymus cancer	0.00441	0.0119	CbGeAlD
Loperamide—CYP2B6—lymphoid tissue—thymus cancer	0.00418	0.0113	CbGeAlD
Loperamide—CALM3—lymph node—thymus cancer	0.00404	0.0109	CbGeAlD
Loperamide—CYP2B6—lung—thymus cancer	0.00345	0.0093	CbGeAlD
Loperamide—ABCB1—hematopoietic system—thymus cancer	0.00317	0.00856	CbGeAlD
Loperamide—CALM2—lymph node—thymus cancer	0.00317	0.00856	CbGeAlD
Loperamide—CALM1—lymph node—thymus cancer	0.00316	0.00852	CbGeAlD
Loperamide—ABCB1—epithelium—thymus cancer	0.0029	0.00783	CbGeAlD
Loperamide—ABCB1—pituitary gland—thymus cancer	0.00235	0.00635	CbGeAlD
Loperamide—ABCB1—lymphoid tissue—thymus cancer	0.00223	0.00603	CbGeAlD
Loperamide—ABCB1—bone marrow—thymus cancer	0.00203	0.00549	CbGeAlD
Loperamide—ABCB1—thyroid gland—thymus cancer	0.00203	0.00548	CbGeAlD
Loperamide—ABCB1—lung—thymus cancer	0.00184	0.00497	CbGeAlD
Loperamide—ABCB1—lymph node—thymus cancer	0.00126	0.0034	CbGeAlD
Loperamide—CALM2—Signaling by FGFR—KIT—thymus cancer	2.01e-05	0.00344	CbGpPWpGaD
Loperamide—CALM2—Signaling by ERBB2—KIT—thymus cancer	2e-05	0.00343	CbGpPWpGaD
Loperamide—CALM1—Signaling by ERBB2—KIT—thymus cancer	2e-05	0.00343	CbGpPWpGaD
Loperamide—CALM2—DAP12 signaling—KIT—thymus cancer	1.99e-05	0.00341	CbGpPWpGaD
Loperamide—CALM1—DAP12 signaling—KIT—thymus cancer	1.99e-05	0.00341	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—CYLD—thymus cancer	1.98e-05	0.0034	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—CYLD—thymus cancer	1.98e-05	0.0034	CbGpPWpGaD
Loperamide—ABCB1—Allograft Rejection—IL2—thymus cancer	1.96e-05	0.00337	CbGpPWpGaD
Loperamide—CALM3—Signaling by FGFR in disease—KIT—thymus cancer	1.93e-05	0.00332	CbGpPWpGaD
Loperamide—CALM3—DAP12 interactions—KIT—thymus cancer	1.93e-05	0.00332	CbGpPWpGaD
Loperamide—CALM3—Fc epsilon receptor (FCERI) signaling—KIT—thymus cancer	1.93e-05	0.00332	CbGpPWpGaD
Loperamide—CALM3—Signaling by EGFR—KIT—thymus cancer	1.91e-05	0.00329	CbGpPWpGaD
Loperamide—CALM3—Signaling by EGFR in Cancer—KIT—thymus cancer	1.9e-05	0.00326	CbGpPWpGaD
Loperamide—CALM3—Signaling by PDGF—KIT—thymus cancer	1.89e-05	0.00324	CbGpPWpGaD
Loperamide—CALM1—DAP12 interactions—KIT—thymus cancer	1.87e-05	0.00321	CbGpPWpGaD
Loperamide—CALM2—DAP12 interactions—KIT—thymus cancer	1.87e-05	0.00321	CbGpPWpGaD
Loperamide—CALM1—Signaling by FGFR in disease—KIT—thymus cancer	1.87e-05	0.00321	CbGpPWpGaD
Loperamide—CALM2—Fc epsilon receptor (FCERI) signaling—KIT—thymus cancer	1.87e-05	0.00321	CbGpPWpGaD
Loperamide—CALM2—Signaling by FGFR in disease—KIT—thymus cancer	1.87e-05	0.00321	CbGpPWpGaD
Loperamide—CALM1—Fc epsilon receptor (FCERI) signaling—KIT—thymus cancer	1.87e-05	0.00321	CbGpPWpGaD
Loperamide—CALM2—Signaling by EGFR—KIT—thymus cancer	1.85e-05	0.00318	CbGpPWpGaD
Loperamide—CALM1—Signaling by EGFR—KIT—thymus cancer	1.85e-05	0.00318	CbGpPWpGaD
Loperamide—POMC—Signaling by GPCR—IL2—thymus cancer	1.85e-05	0.00318	CbGpPWpGaD
Loperamide—CALM2—Signaling by EGFR in Cancer—KIT—thymus cancer	1.84e-05	0.00315	CbGpPWpGaD
Loperamide—CALM1—Signaling by EGFR in Cancer—KIT—thymus cancer	1.84e-05	0.00315	CbGpPWpGaD
Loperamide—CALM1—Signaling by PDGF—KIT—thymus cancer	1.83e-05	0.00314	CbGpPWpGaD
Loperamide—CALM2—Signaling by PDGF—KIT—thymus cancer	1.83e-05	0.00314	CbGpPWpGaD
Loperamide—CALM1—Cardiac Hypertrophic Response—AKT1—thymus cancer	1.82e-05	0.00312	CbGpPWpGaD
Loperamide—CALM2—Cardiac Hypertrophic Response—AKT1—thymus cancer	1.82e-05	0.00312	CbGpPWpGaD
Loperamide—CALM3—B Cell Activation—KIT—thymus cancer	1.79e-05	0.00307	CbGpPWpGaD
Loperamide—CALM2—B Cell Activation—KIT—thymus cancer	1.73e-05	0.00297	CbGpPWpGaD
Loperamide—CALM1—B Cell Activation—KIT—thymus cancer	1.73e-05	0.00297	CbGpPWpGaD
Loperamide—CALM3—Translocation of GLUT4 to the plasma membrane—AKT1—thymus cancer	1.73e-05	0.00297	CbGpPWpGaD
Loperamide—CALM3—NGF signalling via TRKA from the plasma membrane—KIT—thymus cancer	1.71e-05	0.00294	CbGpPWpGaD
Loperamide—CALM2—Translocation of GLUT4 to the plasma membrane—AKT1—thymus cancer	1.67e-05	0.00287	CbGpPWpGaD
Loperamide—CALM1—Translocation of GLUT4 to the plasma membrane—AKT1—thymus cancer	1.67e-05	0.00287	CbGpPWpGaD
Loperamide—CALM3—Alzheimers Disease—TP53—thymus cancer	1.66e-05	0.00286	CbGpPWpGaD
Loperamide—CALM2—NGF signalling via TRKA from the plasma membrane—KIT—thymus cancer	1.66e-05	0.00284	CbGpPWpGaD
Loperamide—CALM1—NGF signalling via TRKA from the plasma membrane—KIT—thymus cancer	1.66e-05	0.00284	CbGpPWpGaD
Loperamide—CALM1—Alzheimers Disease—TP53—thymus cancer	1.61e-05	0.00276	CbGpPWpGaD
Loperamide—CALM2—Alzheimers Disease—TP53—thymus cancer	1.61e-05	0.00276	CbGpPWpGaD
Loperamide—CALM2—Endochondral Ossification—AKT1—thymus cancer	1.61e-05	0.00276	CbGpPWpGaD
Loperamide—CALM1—Endochondral Ossification—AKT1—thymus cancer	1.61e-05	0.00276	CbGpPWpGaD
Loperamide—CALM3—BCR signaling pathway—AKT1—thymus cancer	1.6e-05	0.00275	CbGpPWpGaD
Loperamide—CALM3—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—thymus cancer	1.58e-05	0.00272	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—KIT—thymus cancer	1.55e-05	0.00267	CbGpPWpGaD
Loperamide—CALM2—BCR signaling pathway—AKT1—thymus cancer	1.55e-05	0.00266	CbGpPWpGaD
Loperamide—CALM1—BCR signaling pathway—AKT1—thymus cancer	1.55e-05	0.00266	CbGpPWpGaD
Loperamide—CALM2—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—thymus cancer	1.53e-05	0.00263	CbGpPWpGaD
Loperamide—CALM1—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—thymus cancer	1.53e-05	0.00263	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—MAML2—thymus cancer	1.33e-05	0.00229	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—KIT—thymus cancer	1.32e-05	0.00226	CbGpPWpGaD
Loperamide—CALM2—MicroRNAs in cardiomyocyte hypertrophy—AKT1—thymus cancer	1.29e-05	0.00222	CbGpPWpGaD
Loperamide—CALM1—MicroRNAs in cardiomyocyte hypertrophy—AKT1—thymus cancer	1.29e-05	0.00222	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—KIT—thymus cancer	1.27e-05	0.00219	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—KIT—thymus cancer	1.27e-05	0.00219	CbGpPWpGaD
Loperamide—ABCB1—HIF-1-alpha transcription factor network—AKT1—thymus cancer	1.23e-05	0.00211	CbGpPWpGaD
Loperamide—CALM3—Immune System—CYLD—thymus cancer	1.19e-05	0.00205	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MAML2—thymus cancer	1.17e-05	0.00201	CbGpPWpGaD
Loperamide—CALM2—Immune System—CYLD—thymus cancer	1.15e-05	0.00198	CbGpPWpGaD
Loperamide—CALM1—Immune System—CYLD—thymus cancer	1.15e-05	0.00198	CbGpPWpGaD
Loperamide—CALM3—Platelet activation, signaling and aggregation—IL2—thymus cancer	1.14e-05	0.00195	CbGpPWpGaD
Loperamide—CALM3—ErbB1 downstream signaling—AKT1—thymus cancer	1.12e-05	0.00192	CbGpPWpGaD
Loperamide—POMC—GPCR downstream signaling—AKT1—thymus cancer	1.1e-05	0.0019	CbGpPWpGaD
Loperamide—CALM3—VEGFA-VEGFR2 Pathway—AKT1—thymus cancer	1.1e-05	0.00189	CbGpPWpGaD
Loperamide—CALM1—Platelet activation, signaling and aggregation—IL2—thymus cancer	1.1e-05	0.00189	CbGpPWpGaD
Loperamide—CALM2—Platelet activation, signaling and aggregation—IL2—thymus cancer	1.1e-05	0.00189	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—IL2—thymus cancer	1.09e-05	0.00188	CbGpPWpGaD
Loperamide—CALM2—ErbB1 downstream signaling—AKT1—thymus cancer	1.08e-05	0.00186	CbGpPWpGaD
Loperamide—CALM1—ErbB1 downstream signaling—AKT1—thymus cancer	1.08e-05	0.00186	CbGpPWpGaD
Loperamide—CALM1—VEGFA-VEGFR2 Pathway—AKT1—thymus cancer	1.07e-05	0.00183	CbGpPWpGaD
Loperamide—CALM2—VEGFA-VEGFR2 Pathway—AKT1—thymus cancer	1.07e-05	0.00183	CbGpPWpGaD
Loperamide—CALM3—Signaling by VEGF—AKT1—thymus cancer	1.04e-05	0.00179	CbGpPWpGaD
Loperamide—CALM2—Signaling by VEGF—AKT1—thymus cancer	1.01e-05	0.00173	CbGpPWpGaD
Loperamide—CALM1—Signaling by VEGF—AKT1—thymus cancer	1.01e-05	0.00173	CbGpPWpGaD
Loperamide—POMC—Signaling by GPCR—AKT1—thymus cancer	1e-05	0.00172	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MAML2—thymus cancer	9.89e-06	0.0017	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CD8A—thymus cancer	9.6e-06	0.00165	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CD8A—thymus cancer	9.29e-06	0.00159	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CD8A—thymus cancer	9.29e-06	0.00159	CbGpPWpGaD
Loperamide—CALM3—Disease—MAML2—thymus cancer	8.74e-06	0.0015	CbGpPWpGaD
Loperamide—CALM3—Downstream signaling of activated FGFR—AKT1—thymus cancer	8.46e-06	0.00145	CbGpPWpGaD
Loperamide—CALM2—Disease—MAML2—thymus cancer	8.46e-06	0.00145	CbGpPWpGaD
Loperamide—CALM1—Disease—MAML2—thymus cancer	8.46e-06	0.00145	CbGpPWpGaD
Loperamide—CALM1—Downstream signaling of activated FGFR—AKT1—thymus cancer	8.19e-06	0.00141	CbGpPWpGaD
Loperamide—CALM2—Downstream signaling of activated FGFR—AKT1—thymus cancer	8.19e-06	0.00141	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—IL2—thymus cancer	8.08e-06	0.00139	CbGpPWpGaD
Loperamide—CALM3—Downstream signal transduction—AKT1—thymus cancer	7.95e-06	0.00137	CbGpPWpGaD
Loperamide—CALM3—Signaling by FGFR—AKT1—thymus cancer	7.91e-06	0.00136	CbGpPWpGaD
Loperamide—CALM3—Signaling by ERBB2—AKT1—thymus cancer	7.88e-06	0.00135	CbGpPWpGaD
Loperamide—CALM3—DAP12 signaling—AKT1—thymus cancer	7.84e-06	0.00135	CbGpPWpGaD
Loperamide—CALM2—Downstream signal transduction—AKT1—thymus cancer	7.69e-06	0.00132	CbGpPWpGaD
Loperamide—CALM1—Downstream signal transduction—AKT1—thymus cancer	7.69e-06	0.00132	CbGpPWpGaD
Loperamide—CALM2—Signaling by FGFR—AKT1—thymus cancer	7.66e-06	0.00131	CbGpPWpGaD
Loperamide—CALM1—Signaling by FGFR—AKT1—thymus cancer	7.66e-06	0.00131	CbGpPWpGaD
Loperamide—CALM1—Signaling by ERBB2—AKT1—thymus cancer	7.62e-06	0.00131	CbGpPWpGaD
Loperamide—CALM2—Signaling by ERBB2—AKT1—thymus cancer	7.62e-06	0.00131	CbGpPWpGaD
Loperamide—CALM1—DAP12 signaling—AKT1—thymus cancer	7.58e-06	0.0013	CbGpPWpGaD
Loperamide—CALM2—DAP12 signaling—AKT1—thymus cancer	7.58e-06	0.0013	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—KIT—thymus cancer	7.51e-06	0.00129	CbGpPWpGaD
Loperamide—CALM3—DAP12 interactions—AKT1—thymus cancer	7.37e-06	0.00127	CbGpPWpGaD
Loperamide—CALM3—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	7.37e-06	0.00127	CbGpPWpGaD
Loperamide—CALM3—Signaling by FGFR in disease—AKT1—thymus cancer	7.37e-06	0.00127	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—IL2—thymus cancer	7.34e-06	0.00126	CbGpPWpGaD
Loperamide—CALM3—Signaling by EGFR—AKT1—thymus cancer	7.31e-06	0.00125	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—KIT—thymus cancer	7.26e-06	0.00125	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—KIT—thymus cancer	7.26e-06	0.00125	CbGpPWpGaD
Loperamide—CALM3—Signaling by EGFR in Cancer—AKT1—thymus cancer	7.24e-06	0.00124	CbGpPWpGaD
Loperamide—CALM3—Signaling by PDGF—AKT1—thymus cancer	7.21e-06	0.00124	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—KIT—thymus cancer	7.21e-06	0.00124	CbGpPWpGaD
Loperamide—CALM1—DAP12 interactions—AKT1—thymus cancer	7.13e-06	0.00122	CbGpPWpGaD
Loperamide—CALM2—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	7.13e-06	0.00122	CbGpPWpGaD
Loperamide—CALM1—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	7.13e-06	0.00122	CbGpPWpGaD
Loperamide—CALM2—Signaling by FGFR in disease—AKT1—thymus cancer	7.13e-06	0.00122	CbGpPWpGaD
Loperamide—CALM1—Signaling by FGFR in disease—AKT1—thymus cancer	7.13e-06	0.00122	CbGpPWpGaD
Loperamide—CALM2—DAP12 interactions—AKT1—thymus cancer	7.13e-06	0.00122	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—IL2—thymus cancer	7.09e-06	0.00122	CbGpPWpGaD
Loperamide—POMC—Metabolism—AKT1—thymus cancer	7.09e-06	0.00122	CbGpPWpGaD
Loperamide—CALM1—Signaling by EGFR—AKT1—thymus cancer	7.07e-06	0.00121	CbGpPWpGaD
Loperamide—CALM2—Signaling by EGFR—AKT1—thymus cancer	7.07e-06	0.00121	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—TP53—thymus cancer	7.02e-06	0.0012	CbGpPWpGaD
Loperamide—CALM2—Signaling by EGFR in Cancer—AKT1—thymus cancer	7.01e-06	0.0012	CbGpPWpGaD
Loperamide—CALM1—Signaling by EGFR in Cancer—AKT1—thymus cancer	7.01e-06	0.0012	CbGpPWpGaD
Loperamide—CALM2—Signaling by PDGF—AKT1—thymus cancer	6.97e-06	0.0012	CbGpPWpGaD
Loperamide—CALM1—Signaling by PDGF—AKT1—thymus cancer	6.97e-06	0.0012	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—KIT—thymus cancer	6.97e-06	0.0012	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—KIT—thymus cancer	6.97e-06	0.0012	CbGpPWpGaD
Loperamide—CALM3—Membrane Trafficking—AKT1—thymus cancer	6.97e-06	0.0012	CbGpPWpGaD
Loperamide—CALM3—B Cell Activation—AKT1—thymus cancer	6.82e-06	0.00117	CbGpPWpGaD
Loperamide—CALM2—Membrane Trafficking—AKT1—thymus cancer	6.74e-06	0.00116	CbGpPWpGaD
Loperamide—CALM1—Membrane Trafficking—AKT1—thymus cancer	6.74e-06	0.00116	CbGpPWpGaD
Loperamide—CALM2—B Cell Activation—AKT1—thymus cancer	6.6e-06	0.00113	CbGpPWpGaD
Loperamide—CALM1—B Cell Activation—AKT1—thymus cancer	6.6e-06	0.00113	CbGpPWpGaD
Loperamide—CALM3—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	6.53e-06	0.00112	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—IL2—thymus cancer	6.44e-06	0.00111	CbGpPWpGaD
Loperamide—CALM1—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	6.32e-06	0.00108	CbGpPWpGaD
Loperamide—CALM2—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	6.32e-06	0.00108	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	6.23e-06	0.00107	CbGpPWpGaD
Loperamide—CALM3—Platelet activation, signaling and aggregation—AKT1—thymus cancer	6.17e-06	0.00106	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—KIT—thymus cancer	6.16e-06	0.00106	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—AKT1—thymus cancer	6.12e-06	0.00105	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MAML2—thymus cancer	6.12e-06	0.00105	CbGpPWpGaD
Loperamide—CALM3—RNF mutants show enhanced WNT signaling and proliferation—AKT1—thymus cancer	6.04e-06	0.00104	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—IL2—thymus cancer	5.99e-06	0.00103	CbGpPWpGaD
Loperamide—CALM2—Platelet activation, signaling and aggregation—AKT1—thymus cancer	5.97e-06	0.00103	CbGpPWpGaD
Loperamide—CALM1—Platelet activation, signaling and aggregation—AKT1—thymus cancer	5.97e-06	0.00103	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—AKT1—thymus cancer	5.93e-06	0.00102	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MAML2—thymus cancer	5.92e-06	0.00102	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MAML2—thymus cancer	5.92e-06	0.00102	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—IL2—thymus cancer	5.87e-06	0.00101	CbGpPWpGaD
Loperamide—CALM2—RNF mutants show enhanced WNT signaling and proliferation—AKT1—thymus cancer	5.84e-06	0.001	CbGpPWpGaD
Loperamide—CALM1—RNF mutants show enhanced WNT signaling and proliferation—AKT1—thymus cancer	5.84e-06	0.001	CbGpPWpGaD
Loperamide—CALM3—Immune System—CD8A—thymus cancer	5.82e-06	0.001	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—CD4—thymus cancer	5.74e-06	0.000986	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—IL2—thymus cancer	5.68e-06	0.000975	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—IL2—thymus cancer	5.68e-06	0.000975	CbGpPWpGaD
Loperamide—CALM2—Immune System—CD8A—thymus cancer	5.63e-06	0.000967	CbGpPWpGaD
Loperamide—CALM1—Immune System—CD8A—thymus cancer	5.63e-06	0.000967	CbGpPWpGaD
Loperamide—CALM3—Signaling by WNT in cancer—AKT1—thymus cancer	5.61e-06	0.000963	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—CD4—thymus cancer	5.55e-06	0.000954	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—CD4—thymus cancer	5.55e-06	0.000954	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CD4—thymus cancer	5.51e-06	0.000947	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—IL2—thymus cancer	5.44e-06	0.000934	CbGpPWpGaD
Loperamide—CALM2—Signaling by WNT in cancer—AKT1—thymus cancer	5.43e-06	0.000932	CbGpPWpGaD
Loperamide—CALM1—Signaling by WNT in cancer—AKT1—thymus cancer	5.43e-06	0.000932	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—KIT—thymus cancer	5.4e-06	0.000928	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CD4—thymus cancer	5.33e-06	0.000916	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CD4—thymus cancer	5.33e-06	0.000916	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	5.26e-06	0.000903	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—AKT1—thymus cancer	5.02e-06	0.000862	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—AKT1—thymus cancer	4.86e-06	0.000834	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—AKT1—thymus cancer	4.86e-06	0.000834	CbGpPWpGaD
Loperamide—CALM3—Signaling by Wnt—AKT1—thymus cancer	4.63e-06	0.000794	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—KIT—thymus cancer	4.57e-06	0.000784	CbGpPWpGaD
Loperamide—CALM1—Signaling by Wnt—AKT1—thymus cancer	4.47e-06	0.000768	CbGpPWpGaD
Loperamide—CALM2—Signaling by Wnt—AKT1—thymus cancer	4.47e-06	0.000768	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—AKT1—thymus cancer	4.38e-06	0.000753	CbGpPWpGaD
Loperamide—CALM3—Immune System—KIT—thymus cancer	4.37e-06	0.000751	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—IL2—thymus cancer	4.34e-06	0.000745	CbGpPWpGaD
Loperamide—CALM2—Immune System—KIT—thymus cancer	4.23e-06	0.000726	CbGpPWpGaD
Loperamide—CALM1—Immune System—KIT—thymus cancer	4.23e-06	0.000726	CbGpPWpGaD
Loperamide—CALM3—Disease—KIT—thymus cancer	4.04e-06	0.000693	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—AKT1—thymus cancer	3.98e-06	0.000683	CbGpPWpGaD
Loperamide—CALM2—Disease—KIT—thymus cancer	3.91e-06	0.00067	CbGpPWpGaD
Loperamide—CALM1—Disease—KIT—thymus cancer	3.91e-06	0.00067	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—AKT1—thymus cancer	3.84e-06	0.00066	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IL2—thymus cancer	3.8e-06	0.000653	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—TP53—thymus cancer	3.77e-06	0.000647	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—TP53—thymus cancer	3.65e-06	0.000626	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—TP53—thymus cancer	3.65e-06	0.000626	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—AKT1—thymus cancer	3.49e-06	0.000599	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—IL2—thymus cancer	3.37e-06	0.000578	CbGpPWpGaD
Loperamide—CALM3—Immune System—CD4—thymus cancer	3.34e-06	0.000574	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—IL2—thymus cancer	3.26e-06	0.000559	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—IL2—thymus cancer	3.26e-06	0.000559	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—AKT1—thymus cancer	3.25e-06	0.000558	CbGpPWpGaD
Loperamide—CALM1—Immune System—CD4—thymus cancer	3.23e-06	0.000555	CbGpPWpGaD
Loperamide—CALM2—Immune System—CD4—thymus cancer	3.23e-06	0.000555	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IL2—thymus cancer	3.21e-06	0.000552	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—AKT1—thymus cancer	3.18e-06	0.000546	CbGpPWpGaD
Loperamide—CALM3—Disease—CD4—thymus cancer	3.09e-06	0.00053	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—AKT1—thymus cancer	3.08e-06	0.000528	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—AKT1—thymus cancer	3.08e-06	0.000528	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL2—thymus cancer	3.08e-06	0.000528	CbGpPWpGaD
Loperamide—CALM2—Disease—CD4—thymus cancer	2.99e-06	0.000513	CbGpPWpGaD
Loperamide—CALM1—Disease—CD4—thymus cancer	2.99e-06	0.000513	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL2—thymus cancer	2.98e-06	0.000511	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL2—thymus cancer	2.98e-06	0.000511	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—AKT1—thymus cancer	2.95e-06	0.000506	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—AKT1—thymus cancer	2.86e-06	0.000492	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—KIT—thymus cancer	2.83e-06	0.000485	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TP53—thymus cancer	2.78e-06	0.000478	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—AKT1—thymus cancer	2.77e-06	0.000476	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—AKT1—thymus cancer	2.77e-06	0.000476	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—AKT1—thymus cancer	2.75e-06	0.000472	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—KIT—thymus cancer	2.73e-06	0.00047	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—KIT—thymus cancer	2.73e-06	0.00047	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—AKT1—thymus cancer	2.66e-06	0.000457	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—AKT1—thymus cancer	2.66e-06	0.000457	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TP53—thymus cancer	2.44e-06	0.000419	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—AKT1—thymus cancer	2.35e-06	0.000404	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TP53—thymus cancer	2.06e-06	0.000354	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—AKT1—thymus cancer	2.06e-06	0.000354	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL2—thymus cancer	1.99e-06	0.000342	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL2—thymus cancer	1.92e-06	0.00033	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL2—thymus cancer	1.92e-06	0.00033	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—AKT1—thymus cancer	1.83e-06	0.000314	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—AKT1—thymus cancer	1.77e-06	0.000303	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—AKT1—thymus cancer	1.77e-06	0.000303	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—AKT1—thymus cancer	1.74e-06	0.000299	CbGpPWpGaD
Loperamide—CALM3—Immune System—AKT1—thymus cancer	1.67e-06	0.000286	CbGpPWpGaD
Loperamide—CALM1—Immune System—AKT1—thymus cancer	1.61e-06	0.000277	CbGpPWpGaD
Loperamide—CALM2—Immune System—AKT1—thymus cancer	1.61e-06	0.000277	CbGpPWpGaD
Loperamide—CALM3—Disease—AKT1—thymus cancer	1.54e-06	0.000264	CbGpPWpGaD
Loperamide—CALM2—Disease—AKT1—thymus cancer	1.49e-06	0.000256	CbGpPWpGaD
Loperamide—CALM1—Disease—AKT1—thymus cancer	1.49e-06	0.000256	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—AKT1—thymus cancer	1.33e-06	0.000228	CbGpPWpGaD
Loperamide—CALM3—Metabolism—AKT1—thymus cancer	1.29e-06	0.000221	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TP53—thymus cancer	1.28e-06	0.000219	CbGpPWpGaD
Loperamide—CALM2—Metabolism—AKT1—thymus cancer	1.25e-06	0.000214	CbGpPWpGaD
Loperamide—CALM1—Metabolism—AKT1—thymus cancer	1.25e-06	0.000214	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TP53—thymus cancer	1.24e-06	0.000212	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TP53—thymus cancer	1.24e-06	0.000212	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—AKT1—thymus cancer	1.12e-06	0.000193	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AKT1—thymus cancer	1.08e-06	0.000185	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AKT1—thymus cancer	1.04e-06	0.000179	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AKT1—thymus cancer	1.04e-06	0.000179	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—AKT1—thymus cancer	9.78e-07	0.000168	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—AKT1—thymus cancer	9.21e-07	0.000158	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—AKT1—thymus cancer	6.02e-07	0.000103	CbGpPWpGaD
